Skip to main content
SpringerLink
Log in

ANTITUMOR, ANTI-INVASION, AND ANTIMETASTATIC EFFECTS OF CURCUMIN

  • Chapter
The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease

Part of the book series: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY ((AEMB,volume 595))

Abstract

Curcumin was found to be cytotoxic in nature to a wide variety of tumor cell lines of different tissue origin. The action of curcumin is dependent on with the cell type, the concentration of curcumin (IC50: 2–40 μg/mL), and the time of the treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1. Srimal, R. C. and Dhawan B. N. (1973) Pharmacology of diferuloylmethane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm Pharmacol. 25, 447–452.

    PubMed  CAS  Google Scholar 

  2. 2. Y. J. Surh, Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768–780 (2003).

    Article  PubMed  CAS  Google Scholar 

  3. 3. B. B. Aggarwal, A. Kumar, and A. C. Bharti, Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 23, 363–398 (2003).

    PubMed  CAS  Google Scholar 

  4. 4. R. K. Maheshwari, A. K. Singh, J. Gaddipati, and R. C. Srimal, Multiple biological activities of curcumin: A short review. Life Sci 78, 2081–2087 (2006).

    Article  PubMed  CAS  Google Scholar 

  5. 5. R. Kuttan, P. Bhanumathy, K. Nirmala, and M. C. George, Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29, 197–202 (1985).

    Article  PubMed  CAS  Google Scholar 

  6. 6. K. K. Soudamini. and R. Kuttan, Cytotoxic and tumor reducing properties of curcumin. Indian J Pharmacol 20, 95–101 (1998).

    Google Scholar 

  7. 7. S. Anuchapreeda, P. Thanarattanakorn, S. Sittipreechacharn, P. Chanarat, and P. Limtrakul, Curcumin inhibits WT1 gene expression in human leukemic K562 cells. Acta Pharmacol Sin 27, 360–366 (2006).

    Article  PubMed  CAS  Google Scholar 

  8. 8. S. Anuchapreeda, P. Limtrakul, P. Thanarattanakorn, S. Sittipreechacharn, and P. Chanarat, Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells. Arch Pharm Res 29, 80–87 (2006).

    Article  PubMed  CAS  Google Scholar 

  9. 9. L. X. Wu, J. H. Xu, X. W. Huang, K. Z. Zhang, C. X. We, and Y. Z. Chen, Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90. Acta Pharmacol Sin 27, 694–699 (2006).

    Article  PubMed  CAS  Google Scholar 

  10. 10. S. Chakraborty, U. Ghosh, N. P. Bhattacharyya, R. K. Bhattacharya, and M. Roy, Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res 596, 81–90 (2006).

    PubMed  CAS  Google Scholar 

  11. 11. A. Duvoix, F. Morceau, S. Delhalle, M. Schmitz, M., Schnekenburger, M. M. Galteau, M. Dicato, and M. Diederich, Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol 66, 1475–1483 (2003).

    Article  PubMed  CAS  Google Scholar 

  12. 12. A. R. Hussain, M. Al-Rasheed, P. S. Manogaran, K. A. Al-Hussein, L. C. Platanias, K. Al Kuraya, and S. Uddin, Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11, 245–254 (2006).

    Article  PubMed  CAS  Google Scholar 

  13. 13. J. Rajasingh, H. P. Raikwar, G. Muthian, C. Johnson, and J. J. Bright, Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem Biophys Res Commun 340, 359–368 (2006).

    Article  PubMed  CAS  Google Scholar 

  14. 14. M. Tomita, H. Kawakami, J. N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, and N. Mori, Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30, 313–321 (2006).

    Article  PubMed  CAS  Google Scholar 

  15. 15. M. Tomita, H. Kawakami, J. N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, K. Ohshiro, and N. Mori, Curcumin (diferuloylmethane) inhibits constitutive active NF-κB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer 118, 765–772 (2006).

    Article  PubMed  CAS  Google Scholar 

  16. 16. G. P. Collett and F. C. Campbell, Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 27, 1285–1291 (2006).

    Article  PubMed  CAS  Google Scholar 

  17. 17. A. Kumar and B. B. Aggarwal, Nuclear factor-kB: Its role in health and disease. J Mol Med 82, 434–438 (2004).

    Article  PubMed  CAS  Google Scholar 

  18. 18. A. S. Jaiswal, B. P. Marlow, N. Gupta, and S. Narayan, Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414–8427 (2002).

    Article  PubMed  CAS  Google Scholar 

  19. 19. R. Rashmi, S. Kumar, and D. Karunagaran, Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Carcinogenesis 26, 713–723 (2005).

    Article  PubMed  CAS  Google Scholar 

  20. 20. D. W. Scott and G. Loo, Curcumin-induced GADD153 gene up-regulation in human colon cancer cells. Carcinogenesis 25, 2155–2164 (2004).

    Article  PubMed  CAS  Google Scholar 

  21. 21. S. Narayan, Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways. J Mol Histol 35, 301–307 (2004).

    Article  PubMed  CAS  Google Scholar 

  22. 22. J. Cao, L Jia, H. M. Zhou, Y. Liu, and L. F. Zhong, Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 Cells Toxicol Sci 91, 476–483 (2006).

    Article  CAS  Google Scholar 

  23. 23. D. W. Seol, Q. Chen, and R. Zarnegar, Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1. Oncogene 19, 1132–1137 (2000).

    Article  PubMed  CAS  Google Scholar 

  24. 24. S. H. Jee, S. C. Shen, C. R. Tseng, H. C. Chiu, and M. L. Kuo, Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 111, 656–661 (1998).

    Article  PubMed  CAS  Google Scholar 

  25. 25. S. Aggarwal, Y. Takada, S. Singh, J. N. Myers, and B. B. Aggarwal, Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling. Int J Cancer 111, 679–692 (2004).

    Article  PubMed  CAS  Google Scholar 

  26. 26. C. Ramachandran, S. Rodriguez, R. Ramachandran, P. K. Raveendran Nair, H. Fonseca, Z. Khatib, E. Escalon, and S. J. Melnick, Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 25, 3293–3302 (2005).

    PubMed  CAS  Google Scholar 

  27. 27. S. Qiu, S. S. Tan, J. A. Zhang, A. Liu, J. Y. Yuan, G. Z. Rao, and W. Y. Wang, Apoptosis induced by curcumin and its effect on c-myc and caspase-3 expressions in human melanoma A375 cell line. Di Yi Jun Yi Da Xue Xue Bao 25, 1517–1521 (2005).

    PubMed  CAS  Google Scholar 

  28. 28. J. A. Bush, K. J. Cheung, Jr., and G. Li, Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271, 305–314 (2001).

    Article  PubMed  CAS  Google Scholar 

  29. 29. M. Zheng, S. Ekmekcioglu, E. T. Walch, C. H. Tang, and E. A. Grimm, Inhibition of nuclear factor-κB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 14, 165–171 (2004).

    Article  PubMed  CAS  Google Scholar 

  30. 30. K. Elizabeth and M. N. A. Rao, Effect of curcumin on hydroxyl radical generation through Fenton reaction. Int J Pharm 57, 173–176 (1989).

    Article  Google Scholar 

  31. 31. K. Elizabeth and M. N. A. Rao, Oxygen radical scavenging activity of curcumin. Int J Pharm 58, 237–240 (1990).

    Article  Google Scholar 

  32. 32. T. Atsumi, K. Tonosaki, and S. Fujisawa, Induction of early apoptosis and ROS-generation activity in human gingival fibroblasts (HGF) and human submandibular gland carcinoma (HSG) cells treated with curcumin. Arch Oral Biol 51, 913–921 (2006).

    Article  PubMed  CAS  Google Scholar 

  33. 33. J. Skommer, D. Wlodkowic, and J. Pelkonen, Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines. Exp Hematol 34, 463–474 (2006).

    Article  PubMed  CAS  Google Scholar 

  34. 34. R. J. Anto, G. Kuttan, and R. Kuttan, Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94, 79–83 (1995).

    Article  Google Scholar 

  35. 35. R. J. Anto, J. George, K. D. Babu, K. N. Rajasekharan, and R Kuttan, Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res 370, 127–131 (1996).

    Article  PubMed  CAS  Google Scholar 

  36. 36. S. Pal, T. Choudhuri, S. Chattopadhyay, A. Bhattacharya, G. K. Datta, T. Das, and G. Sa, Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun 288, 658–665 (2001).

    Article  PubMed  CAS  Google Scholar 

  37. 37. N. N. Mahmoud, A. M. Carothers, D. Grunberger, R. T. Bilinski, M. R. Churchill, C. Martucci, H. L. Newmark, and M. M. Bertagnolli, Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921–927 (2000).

    Article  PubMed  CAS  Google Scholar 

  38. 38. M. Churchill, A. Chadburn, R. T. Bilinski, and M. M. Bertagnolli, Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89, 169–175 (2000).

    Article  PubMed  CAS  Google Scholar 

  39. 39. K. K. Soudamini and R. Kuttan, Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol 27, 227–233 (1989).

    Article  PubMed  CAS  Google Scholar 

  40. 40. M. T. Huang, Y. R. Lou, W. Ma, H. L. Newmark, R. K. Reuhl, and A. H. Conney, Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54, 5841–5847 (1994).

    PubMed  CAS  Google Scholar 

  41. 41. M. Nagabhushan and S.V. Bhide, Curcumin as an inhibitor of cancer. J Am Coll Nutr 11,192–198 (1992).

    PubMed  CAS  Google Scholar 

  42. 42. M. T. Huang, R. C. Smart, C. Q. Wong, and A. H. Conney, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48, 5941–5946 (1988).

    PubMed  CAS  Google Scholar 

  43. 43. M. T. Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A. H. Conney, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51, 813–819 (1991).

    PubMed  CAS  Google Scholar 

  44. 44. A. H. Conney, T. Lysz, T. Ferraro, T. F. Abidi, P. S. Manchand, J. D. Laskin, and M. T. Huang, Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 31, 385–396 (1991).

    Article  PubMed  CAS  Google Scholar 

  45. 45. S. V. Singh, X. Hu, S. K. Srivastava, M. Singh, H. Xia, J. L. Orchard, and H. A. Zaren, Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis 19, 1357–1360 (1998).

    Article  PubMed  CAS  Google Scholar 

  46. 46. C. V. Rao, B. Simi, and B. S. Reddy, Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14, 2219–2225 (1993).

    Article  PubMed  CAS  Google Scholar 

  47. 47. J. Ushida, S. Sugie, K. Kawabata, Q. V. Pham, T. Tanaka, K. Fujii, H. Takeuchi, Y. Ito, and H. Mori, Chemopreventive effect of curcumin on N-nitroso methyl benzylamine-induced esophageal carcinogenesis in rats. Jpn J Cancer Res 91, 893–898 (2000).

    PubMed  CAS  Google Scholar 

  48. 48. S. E. Chuang, M. L. Kuo, C. H. Hsu, C. R. Chen, J. K. Lin, G. M. Lai, C. Y. Hsieh, and A. L. Cheng, Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21, 331–335 (2000).

    Article  PubMed  CAS  Google Scholar 

  49. 49. K. B. Soni, A. Rajan, and R. Kuttan, Reversal of aflatoxin induced liver damage by turmeric and curcumin. Cancer Lett 66, 115–121 (1992).

    Article  PubMed  CAS  Google Scholar 

  50. 50. A. Sini, R. Kuttan, and G. Kuttan, Immunomodulatory activity of curcumin. Immunol Invest 28, 291–303 (1999).

    Google Scholar 

  51. 51. V. S. Yadav, K. P. Mishra, D. P. Singh, S. Mehrotra, and V. K. Singh, Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27, 485–497 (2005).

    Article  PubMed  CAS  Google Scholar 

  52. 52. H. Hidaka, T. Ishiko, T. Furuhashi, H. Kamohara, S. Suzuki, M. Miyazaki, O. Ikeda, S. Mita, T. Setoguchi, and M. Ogawa, Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95, 1206–1214 (2002).

    Article  PubMed  CAS  Google Scholar 

  53. 53. G. A. Laquerriere, S. C. Gangloff, R. Le Naour, C. Trentesaux, W. Hornebeck, and M. Guenounou, Relative contribution of NF-κB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18, 168–177 (2002).

    Article  CAS  Google Scholar 

  54. 54. B. Y. Kang, S. W. Chung, W. Chung, S. Im, S. Y. Hwang, and T. S. Kim, Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 384, 191–195 (1999).

    Article  PubMed  CAS  Google Scholar 

  55. 55. M. M. Chan, Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49, 1551–1556n (1995).

    Article  PubMed  CAS  Google Scholar 

  56. 56. L. A. Liotta, Tumor invasion and metastasis; role of the basement membrane. Am.J.Pathol 117, 339–348 (1984).

    PubMed  CAS  Google Scholar 

  57. 57. L. A. Liotta, Tumor invasion and metastasis; role of extracellular matrix. Cancer Res 46, 1–7 (1986).

    Article  PubMed  CAS  Google Scholar 

  58. 58. B. E. Bachmeier, C. M. Iancu, M. Jochum, and A. G. Nerlich, Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther 5, 149–163 (2005).

    Article  PubMed  CAS  Google Scholar 

  59. 59. L. G. Menon, R. Kuttan, and G. Kuttan, Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 95, 221–225 (1995).

    Article  PubMed  CAS  Google Scholar 

  60. 60. L. G. Menon, R. Kuttan, and G. Kuttan, Anti-metastatic activity of curcumin and catechin. Cancer Lett 141, 159–165 (1999).

    Article  PubMed  CAS  Google Scholar 

  61. 61. A. Banerji, J. Chakrabarti, A. Mitra, and A. Chatterjee, Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett 211, 235–242 (2004).

    Article  PubMed  CAS  Google Scholar 

  62. 62. S. Ray, N. Chattopadhyay, A. Mitra, M. Siddiqi, and A. Chatterjee, Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J Environ Pathol Toxicol Oncol 22, 49–58 (2003).

    PubMed  CAS  Google Scholar 

  63. 63. J. H. Hong, K. S. Ahn, E. Bae, S. S. Jeon, and H. Y. Choi, The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 9, 147–152 (2006).

    Article  PubMed  CAS  Google Scholar 

  64. 64. B. B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R. A. Newman, C. E. Bueso-Ramos, and J. E. Price, Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490–7498 (2005).

    Article  PubMed  CAS  Google Scholar 

  65. 65. K. W. Lee, J. H. Kim, H. J. Lee, and Y. J. Surh, Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-κB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 7, 1612–1620 (2005).

    Article  PubMed  CAS  Google Scholar 

  66. 66. S. Philip, A. Bulbule, and G. C. Kundu, Matrix metalloproteinase-2: Mechanism and regulation of NF-κB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj J 21, 429–441 (2004).

    Article  PubMed  CAS  Google Scholar 

  67. 67. N. Frank, J. Knauft, F. Amelung, J. Nair, H. Wesch, and H. Bartsch, No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat Res 523–524, 127–135 (2003).

    PubMed  Google Scholar 

Download references

Authors
  1. Girija Kuttan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kuzhuvelil B. Hari Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chandrasekharan Guruvayoorappan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ramadasan Kuttan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ransom Horne, Jr., Professor of Cancer Research Professor of Cancer Medicine (Biochemistry)and Chief, Cytokine Research Section Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston,, TX, 143, 77030, USA

    Bharat B. Aggarwal Ph.D.

  2. Chief and Professor National Research Laboratory of Molecular Carcinogenesis and Chemoprevention College of Pharmacy, Seoul National University, Shillim-dong, Kwanak-gu, Seoul, 151-742, South Korea

    Young-Joon Surh Ph.D.

  3. Assistant Professor Department of Biology, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA

    Shishir Shishodia Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer

About this chapter

Cite this chapter

Kuttan, G., Hari Kumar, K.B., Guruvayoorappan, C., Kuttan, R. (2007). ANTITUMOR, ANTI-INVASION, AND ANTIMETASTATIC EFFECTS OF CURCUMIN. In: Aggarwal, B.B., Surh, YJ., Shishodia, S. (eds) The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, vol 595. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-46401-5_6

Download citation

Publish with us

Policies and ethics

Search

Navigation